1 / 15

China Integrated Programs for Research on AIDS China CIPRA

2. Outline of China CIPRA. CIPRA: Comprehensive International Program of Research on AIDS Sponsor: National Institute of Health, USACorporation: National Center for STD/AIDS prevention and control, China CDCPeriod: July 1, 2002 to June 30, 2007Budget: $15 millionsProject provinces: Shanxi and Y

merrill
Download Presentation

China Integrated Programs for Research on AIDS China CIPRA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. 1

    2. 2 Outline of China CIPRA CIPRA: Comprehensive International Program of Research on AIDS Sponsor: National Institute of Health, USA Corporation: National Center for STD/AIDS prevention and control, China CDC Period: July 1, 2002 to June 30, 2007 Budget: $15 millions Project provinces: Shanxi and Yunnan

    3. 3 Overall Goal To strengthen the existing HIV/AIDS research infrastructure in China and build the capacity to conduct multidisciplinary research to explore promising strategies for HIV/AIDS prevention, treatment and control.

    4. 4 Research Group The China CIPRA project is composed of 143 research staffs and 12 international consultants. The China CIPRA team is composed of 24 collaborating organizations including 13 domestic research institutes, 2 universities, and 2 hospitals, as well as 5 international universities and 2 research institutions.

    5. 5 Research Activity (I) To estimate the prevalence and incidence of HIV-1 infection and to determine risk factors. To evaluate the efficacy of more intensive, theoretically-based HIV skill-focused interventions for HIV+ adults. To study viral and host factors that correlate with transmission of infection and factors that determine disease progression; and identify the immunodominant CTL epitopes and their MHC restricting elements in the most prevalent Chinese HIV subtypes as well as provide reagents for these studies.

    6. 6 Research Activity (II) 4. To characterize the clinical presentations of AIDS patients in China, to conduct clinical trials of antiviral drugs; 5. To develop vaccine candidates based on the Chinese prevalent strains and to conduct Phase I and Phase II clinical trials to evaluate its safety, immunogenicity and preliminary efficacy.

    7. 7

    8. 8 CIPRA Coordinating Committee(CCC) The CCC is responsible for supervising the general research direction according to the goals of Chinese AIDS control and prevention effort.  It will provide guidance and support for the implementation of the China CIPRA research protocol and schedule. In addition, the committee will translate the experiences and results of the China CIPRA program to help advance AIDS research throughout the country.

    9. 9 Scientific Advisory Board (SAB) Made up of independent domestic and international experts who are not affiliated with the research team.  Responsibilities include: assisting with the planning and implementation of the research protocol; receiving research progress reports on a regular basis; aiding in the resolution of research difficulties encountered; providing an independent assessment on a regular basis of the current status of research project

    10. 10 Monitoring Group on Quality Control (MGQC) This committee is composed of Chinese and international experts and is in charge of maintaining the quality of data generated from this project.  The main responsibility of this group is to supervise the quality of the study based on the overall aims and goals of the China CIPRA plan.  They will oversee quality control in the following areas: epidemiology, laboratory techniques, experiment quality, clinical studies, and particular research related to the GCP standards.  This group will also evaluate the appropriateness of the consent forms and any pertinent ethical issues.  They will scrutinize and provide feedback to the researchers to assure the future quality of the research.

    11. 11

    12. 12 Summary of Progress Set up the administration structure and research team; Conducted preparation work at Shanxi local sites; Developed research protocols; Created SOPs for CIPRA team (on going); Organized training according to the plan;IRB, GCP, management, research techniques, etc. Some researchers were trained oversea Strengthened communication among projects and cores, and communication with international organizations. Created web site and newsletter (electronic/paper version).

    13. 13 Training Information Welcome Project Management and Coordination Leadership and Organization 2 to 3 month/course advanced course preferred

    14. 14 Contact information Address: 4 Nan Wei Road, Room 510 Xuan Wu District Beijing, China 100050 Tel: 86-10-63045970; 63015577 ex. 6510 Fax: 86-10-63045970 E-mail: cipracn@public3.bta.net.cn Website: http://www.chinaids.org.cn/cipra

    15. 15

More Related